Interleukin 4, interleukin 4 receptor-α and interleukin 10 gene polymorphisms in Chagas disease

Parasite Immunology

Volumn 33, Issue 9, 2011, Pages 506-511

  Florez O ^a   Martin J ^b   González Rugeles, Clara Isabel ^a  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Chagas disease; Colombia; Interleukin 10; Interleukin 4; Interleukin 4 receptor alpha; Single nucleotide polymorphism; Trypanosoma cruzi

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA;

ADULT; ARTICLE; CHAGAS DISEASE; COLOMBIA; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRYPANOSOMA CRUZI;

ANTIGENS, PROTOZOAN; CASE-CONTROL STUDIES; CHAGAS CARDIOMYOPATHY; COLOMBIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 80051611759     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2011.01314.x     Document Type: Article

References (40)

1. World Health Organization. Control of Chagas' disease (Report of a WHO expert committee). WHO Technical Report Series, 2007; 11-12.
2. Cunha-Neto E, Nogueira LG, Teixeira PC, et al. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem Inst Oswaldo Cruz 2009; 104(Suppl 1): 252-258.
3. Calzada JE, Nieto A, Beraun Y & Martin J. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 2001; 58: 154-158.
4. Florez O, Zafra G, Morillo C, Martin J & Gonzalez CI. Interleukin-1 gene cluster polymorphism in chagas disease in a Colombian case-control study. Hum Immunol 2006; 67: 741-748.
5. Zafra G, Morillo C, Martin J, Gonzalez A & Gonzalez CI. Polymorphism in the 3' UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes Infect 2007; 9: 1049-1052.
6. Colorado IA, Acquatella H, Catalioti F, Fernandez MT & Layrisse Z. HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection. Hum Immunol 2000; 61: 320-325.
7. Rodriguez-Perez JM, Cruz-Robles D, Hernandez-Pacheco G, et al. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett 2005; 98: 97-102.
8. Nieto A, Beraun Y, Collado MD, et al. HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 2000; 55: 195-198.
9. Calzada JE, Beraun Y, Gonzalez CI & Martin J. Transforming growth factor beta 1 (TGFbeta1) gene polymorphisms and Chagas disease susceptibility in Peruvian and Colombian patients. Cytokine 2009; 45: 149-153.
10. Torres OA, Calzada JE, Beraun Y, et al. Association of the macrophage migration inhibitory factor-173G/C polymorphism with Chagas disease. Hum Immunol 2009; 70: 543-546.
11. Costa GC, da Costa Rocha MO, Moreira PR, et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 2009; 199: 451-454.
12. Jankovic D, Sher A & Yap G. Th1/Th2 effector choice in parasitic infection: decision making by committee. Curr Opin Immunol 2001; 13: 403-409.
13. Langhorne J, Cross C, Seixas E, Li C & von der Weid T. A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc Natl Acad Sci USA 1998; 95: 1730-1734.
14. Higuchi ML, Benvenuti LA, Martins RM & Metzger M. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 2003; 60: 96-107.
15. Klein W, Tromm A, Griga T, et al. Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Genes Immun 2001; 2: 287-289.
16. D'Alfonso S, Rampi M, Rolando V, Giordano M & Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region. Genes Immun 2000; 1: 231-233.
17. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ & Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
18. Nakashima H, Miyake K, Inoue Y, et al. Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun 2002; 3: 107-109.
19. Mitsuyasu H, Izuhara K, Mao XQ, et al. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 1998; 19: 119-120.
20. Nelms K, Keegan AD, Zamorano J, Ryan JJ & Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17: 701-738.
21. Moreno O, Gonzalez CI, Saaibi DL, et al. Polymorphisms in the IL4 and IL4RA genes in Colombian patients with rheumatoid arthritis. J Rheumatol 2007; 34: 36-42.
22. Wilson JN, Rockett K, Jallow M, et al. Analysis of IL10 haplotypic associations with severe malaria. Genes Immun 2005; 6: 462-466.
23. Miller SA, Dykes DD & Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
24. Noguchi E, Shibasaki M, Arinami T, et al. Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 1998; 28: 449-453.
25. Novak N, Kruse S, Kraft S, et al. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol 2002; 119: 870-875.
26. Mujica-Lopez KI, Flores-Martinez SE, Ramos-Zepeda R, et al. Association analysis of polymorphisms in the interleukin-4 receptor (alpha) gene with atopic asthma in patients from western Mexico. Eur J Immunogenet 2002; 29: 375-378.
27. Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JA & Welsh KI. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000; 85: 1984-1988.
28. Mullighan CG, Marshall SE, Bunce M & Welsh KI. Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency. Genes Immun 1999; 1: 137-148.
29. Gauderman WJ. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002; 155: 478-484.
30. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
31. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251-253.
32. Manly KF. Reliability of statistical associations between genes and disease. Immunogenetics 2005; 57: 549-558.
33. Excoffier L, Laval G & Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 2005; 1: 47-50.
34. Barrett JC, Fry B, Maller J & Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
35. Stephenson L, Johns MH, Woodward E, Mora AL & Boothby M. An IL-4R alpha allelic variant, I50, acts as a gain-of-function variant relative to V50 for Stat6, but not Th2 differentiation. J Immunol 2004; 173: 4523-4528.
36. Yao Y, Li W, Kaplan MH & Chang CH. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med 2005; 201: 1899-1903.
37. Hochrein H, O'Keeffe M, Luft T, et al. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med 2000; 192: 823-833.
38. Tarleton RL, Grusby MJ & Zhang L. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. J Immunol 2000; 165: 1520-1525.
39. Moreno M, Silva EL, Ramirez LE, Palacio LG, Rivera D & Arcos-Burgos M. Chagas' disease susceptibility/resistance: linkage disequilibrium analysis suggests epistasis between major histocompatibility complex and interleukin-10. Tissue Antigens 2004; 64: 18-24.
40. D'Avila DA, Guedes PM, Castro AM, Gontijo ED, Chiari E & Galvao LM. Immunological imbalance between IFN-gamma and IL-10 levels in the sera of patients with the cardiac form of Chagas disease. Mem Inst Oswaldo Cruz 2009; 104: 100-105.